RNXT
RenovoRx Inc

3,269
Mkt Cap
$32.36M
Volume
511,360.00
52W High
$1.45
52W Low
$0.7006
PE Ratio
-2.48
RNXT Fundamentals
Price
$0.883
Prev Close
$0.865
Open
$0.92
50D MA
$0.9554
Beta
1.04
Avg. Volume
353,936.90
EPS (Annual)
-$0.3958
P/B
4.01
Rev/Employee
$4,300.00
$21.85
Loading...
Loading...

About

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10

Frequently Asked Questions

What is Market Cap of RenovoRx Inc?
What is the 52-week high for RenovoRx Inc?
What is the 52-week low for RenovoRx Inc?
What is RenovoRx Inc stock price today?
What was RenovoRx Inc stock price yesterday?
What is the PE ratio of RenovoRx Inc?
What is the Price-to-Book ratio of RenovoRx Inc?
What is the 50-day moving average of RenovoRx Inc?
How many employees does RenovoRx Inc have?

Latest RNXT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.